These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14967444)

  • 1. A simple alpha/beta-independent method to derive fully isoeffective schedules following changes in dose per fraction.
    Joiner MC
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):871-5. PubMed ID: 14967444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the temporal pattern of radiation: an IMRT based study.
    Altman MB; Chmura SJ; Deasy JO; Roeske JC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):898-905. PubMed ID: 17011463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy.
    Suwinski R; Wzietek I; Tarnawski R; Namysl-Kaletka A; Kryj M; Chmielarz A; Wydmanski J
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):793-9. PubMed ID: 17499451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
    Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha/beta ratio for arteriovenous malformations estimated from obliteration rates after fractionated and single-dose irradiation.
    Kocher M; Wilms M; Makoski HB; Hassler W; Maarouf M; Treuer H; Voges J; Sturm V; Müller RP
    Radiother Oncol; 2004 Apr; 71(1):109-14. PubMed ID: 15066303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is one Gy equal to one Gy after treatment interruptions?
    Grillo-Ruggieri F; Mantello G
    Rays; 2004; 29(3):275-8. PubMed ID: 15603297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical radiobiology of stage T2-T3 bladder cancer.
    Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.
    Gay HA; Jin JY; Chang AJ; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e81-7. PubMed ID: 23141886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biologic relevance of daily dose variations in adaptive treatment planning.
    Bortfeld T; Paganetti H
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):899-906. PubMed ID: 16751072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculation of isoeffective doses and the alpha/beta value by comparing results following radiosurgery and radiotherapy for arteriovenous malformations of the brain.
    Karlsson B; Lax I; Yamamoto M; Söderman M; Jokura H; Rosen C; Bailes J
    J Neurosurg; 2006 Dec; 105 Suppl():183-9. PubMed ID: 18503354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
    Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
    Paganetti H
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study.
    Guerrero M; Li XA; Earl MA; Sarfaraz M; Kiggundu E
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1513-22. PubMed ID: 15275739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose.
    Park CS; Kim Y; Lee N; Bucci KM; Quivey JM; Verhey LJ; Xia P
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):925-32. PubMed ID: 15936579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumor repopulation on radiotherapy planning.
    Wang JZ; Li XA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.